结合ATP的磁带载体和HDL抑制了造血干细胞的增殖
Laurent Yvan-Charvet1, Tamara Pagler, Emmanuel L Gautier
1Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY 10032, USA. ly2159@columbia.edu
概括
缺乏ABCA1和ABCG1载体的小鼠显示白细胞和干细胞增加,导致疾病. 恢复高密度脂蛋白 (HDL) 水平扭转了这些影响,表明胆固醇运输和血细胞增殖之间存在联系.
科学领域:
- 心血管生物学 心血管生物学
- 血液形成 血液形成 血液形成
- 动脉样硬化研究 动脉样硬化研究
背景情况:
- 白细胞病,特别是单细胞病,与动脉样硬化有关.
- 导致白细胞数量升高的机制尚不清楚.
- 腺三酸盐结合盒 (ABC) 载体ABCA1和ABCG1对于胆固醇从巨细胞流出至关重要,并抑制动脉样硬化.
研究的目的:
- 研究ABCA1和ABCG1在调节造血干细胞和原生细胞群中的作用.
- 了解ABC转运体,白细胞体和动脉样硬化发育之间的联系.
主要方法:
- 产生和分析缺少ABCA1和ABCG1.1的小鼠.
- 骨髓移植的实验. 骨髓移植的实验.
- 血液造血干细胞和原生细胞 (LSK) 种群的评估.
- 评估白细胞症,骨髓扩散性疾病和动脉样硬化.
主要成果:
- 缺少ABCA1和ABCG1的小鼠表现出白细胞症,这是一个骨髓增殖性疾病,并扩展了Lin(-) Sca-1(+) Kit+ (LSK) 干细胞和原始细胞.
- 将Abca1(-/-)Abcg1(-/-) 骨髓移植到高密度脂蛋白 (HDL) 转基因小鼠中,抑制了LSK扩张和白细胞形成.
- 这种移植也逆转了骨髓增殖性疾病,但加速了动脉样硬化.
结论:
- ABCA1,ABCG1和HDL在造血干细胞和多潜原生细胞的增殖中起着关键的抑制作用.
- 这些干细胞和祖细胞种群的扩张与白细胞症和加速动脉样硬化直接相关.
- 这些发现在动脉样硬化背景下,建立了胆固醇外流途径和血液细胞生产调节之间的新鲜联系.
相关概念视频
Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Production of Formed Elements
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...


